Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.333NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.333NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.333NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCYNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCYNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
HK.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-20449.7China
JN.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EK.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EF.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EF.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EF.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BU.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BU.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BU.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used